Abstract
Diabetes mellitus is associated with an increased risk of Alzheimer’s dementia and cognitive decline. The cause of neurodegeneration in chronic diabetic patients remains unclear. Changes in brain microglial activity due to glycemic fluctuations may be an etiological factor. Here, we examined the impact of acute ambient glucose fluctuations on BV-2 microglial activity. Biochemical parameters were assayed and showed that the shift from normal glucose (NG; 5.5 mM) to high glucose (HG; 25 mM) promoted cell growth and induced oxidative/inflammatory stress and microglial activation, as evidenced by increased MTT reduction, elevated pro-inflammatory factor secretion (i.e., TNF-α and oxygen free radicals), and upregulated expression of stress/inflammatory proteins (i.e., HSP70, HO-1, iNOS, and COX-2). Also, LPS-induced inflammation was enlarged by an NG-to-HG shift. In contrast, the HG-to-NG shift trapped microglia in a state of metabolic stress, which led to apoptosis and autophagy, as evidenced by decreased Bcl-2 and increased cleaved caspase-3, TUNEL staining, and LC3B-II expression. These stress episodes were primarily mediated through MAPKs, PI3K/Akt, and NF-κB cascades. Our study demonstrates that acute glucose fluctuation forms the stress that alters microglial activity (e.g., inflammatory activation or self-degradation), representing a novel pathogenic mechanism for the continued deterioration of neurological function in diabetic patients.
Similar content being viewed by others
Introduction
Diabetes mellitus (DM) is closely associated with pathological alterations in the cerebral microvasculature, which lead to cognitive deficits and an increased risk of Alzheimer’s disease (AD)1,2,3. The brain uses glucose as a primary energy source; thus, glucose metabolism dysfunction may be responsible for cerebral complications in diabetic patients. The symptoms of diabetes, including hyperglycemia, obesity, increased blood triacylglycerol concentration, and insulin resistance, are risk factors that increase the probabilities of synaptic loss, impaired neurogenesis, neuronal death, and eventual cognitive decline4,5. Studies have identified several pathophysiological mechanisms in diabetic neurodegeneration, including oxidative stress, mitochondrial dysfunction, and neuroinflammation2,4. The cause of cognitive dysfunction and neurodegeneration in diabetic patients remains poorly understood, hence the etiological factors leading to the continued neurological deterioration in DM require additional study.
The progressive neurodegeneration observed in the diabetic brain is likely caused by the long-term effects of diabetes-induced metabolic alterations and dysglycemia, such as hyperglycemia, hypoglycemia, and acute glycemic fluctuations3,6. Actually, diabetic neuropathy is closely associated with glucose-induced neurotoxicity resulting from excessive advanced glycation end products (AGEs), osmotic stress eliciting damage to the blood brain barrier (BBB), and the leak of toxic substances leading to neuronal injury and inflammation-related glial activation3,7,8. Hyperglycemia is a recognized risk factor for cognitive impairment. Specifically, the amplification of oxidative stress and inflammation by hyperglycemia causes deleterious effects on cerebral function by increasing the production of free radicals and circulating cytokines while impairing antioxidant and innate immune defences9. Glycemic variability has been proposed to promote cognitive dysfunction6,10; however, the impact of acute glycemic fluctuations between peaks and nadirs on neural cells is less documented. Both upward (postprandial) and downward (interprandial) acute changes in glycemia may enhance neural damage during chronic brain inflammation, and thus enlarge and accelerate the deterioration of cognitive performance in diabetic patients.
Microglia play an important role in diabetic neuropathy. In experimentally-induced diabetic mouse models, microglial proliferation and activation were observed in the brain; in addition, activated microglia largely contributed to neuroinflammatory processes and oxidative stress11,12,13. Thus, the microglial activity (e.g., chronic activation or self-degradation) associated with enhancing neurodestructive effects or withdrawing neurotrophic effects should be a concern in diabetic brains. Microglia are the most susceptible to pathological brain changes, and BBB injury is apparent in diabetes14; hence, glycemic variability may easily disturb microglial activity during BBB dysfunction. To the best of our knowledge, the response of microglia to acute glucose fluctuations remains unclear.
In this study, we examined whether cerebral glycemic variability played a crucial role leading to the disturbance of microglial activity using an in vitro culture model of murine BV-2 microglial cells. To mimic in vivo acute fluctuations in glycemia, we rapidly shifted from normal to high glucose (NG-to-HG) and from high to normal glucose (HG-to-NG). Biochemical parameters and cell fates after glucose shifts were evaluated as a measure of microglial activity. Here we provide reliable data illustrating that the stress ascribed to acute fluctuations in surrounding glucose induces inflammatory activation or self-degradation in microglia.
Results
An NG-to-HG shift increases microglial proliferation and GLUT2 expression
Alterations in the brain environment can trigger neural cell reactivity, followed by adaptation or maladaptation. Once the BBB is damaged, brain glycemic variability can disturb microglial reactivity. We first examined whether glucose fluctuations affect the growth profile of microglia. Two BV-2 cell lines were separately cultured in NG and HG media. As expected, cells incubated in constant HG conditions exhibited higher proliferation than cells cultured in constant NG conditions. NG-cultured cells exposed to an NG-to-HG shift showed a substantial increase in proliferation when compared with cells under constant NG conditions; however, HG-cultured cells receiving an HG-to-NG shift showed a marked decrease in proliferation when compared with cells under constant HG conditions (Fig. 1a and Supplementary Fig. 1). Subsequently, we investigated whether an adaptive change in the expression of GLUT proteins occurs when microglia experience glucose fluctuations. The expression of GLUT2, but not GLUT1, was increased and decreased in response to NG-to-HG and HG-to-NG shifts, respectively (Fig. 1b,c). Regrettably, GLUT5, which is known to be specific for microglia, did not respond to glucose fluctuations (Supplementary Fig. 2). When GLUT2 was knockdowned by RNAi (i.e., GLUT2 siRNA) in NG-cultured cells, no increased GLUT2 expression was found after an NG-to-HG shift (Fig. 1d). Also, a similar proliferation pattern was observed between constant NG-cultured cells and GLUT2-silenced NG-cultured cells receiving an NG-to-HG shift (Fig. 1e). Therefore, our findings suggest that an NG-to-HG shift causes an adaptive increase in microglial proliferation that positively correlates with GLUT2 upregulation. The upregulation in GLUT2 protein may be essential for the machinery that increases microglial proliferation after experiencing an NG-to-HG shift.
An NG-to-HG shift activates microglia, leading to an upregulation of stress and inflammatory proteins
Although glucose fluctuations trigger cellular/molecular changes that enable microglia to adapt to the environment, we speculated that these fluctuations act as a stressor that elicits dramatic changes in microglial activity. Stress responses from a cell adapting to unfavorable environmental conditions are typically mediated via stress proteins. We examined HSP70 and HO-1 because both are cytoprotective and stress-inducible proteins in several experimental models, including global ischemia and oxidative stress-induced gliotoxicity15,16. Cells exposed to an NG-to-HG shift showed upregulated levels of HSP70 and HO-1 within 3 days when compared with cells in constant NG conditions. Also, a reverse in the elevation of stress proteins was observed after an HG-to-NG shift in HG-cultured cells (Fig. 2a,b).
The appearance of stress proteins implies that stress is occurring. Thus, microglial activity in response to acute glucose fluctuations was evaluated. Activation is essential for a cell’s response to external stimuli and is typically featured by protein neo-synthesis or elevated enzyme activity to accelerate and amplify intracellular biochemical reactions. Given that iNOS and COX-2 upregulation correlates with pathological stress, such as neuroinflammation characterized by microglial activation and the production of inflammatory factors17. The neo-synthesis of these inflammatory proteins was assayed as a marker of microglial activation. NG-cultured cells exposed to an NG-to-HG shift showed iNOS and COX-2 upregulation when compared with cells in constant NG conditions. Furthermore, a considerably gradual decline in the upregulation of iNOS and COX-2 proteins was observed after HG-cultured cells were exposed to an HG-to-NG shift (Fig. 2c,d). These findings suggest that an acute fluctuation from NG to HG forms a stress that induces microglial activation, and this activation is reversed by an HG-to-NG shift.
An NG-to-HG shift induces the release of pro-inflammatory factors from activated microglia
Chronic hyperglycemia and glycemic variability can induce pro-inflammatory conditions18; thus, inflammation plays a crucial role in diabetes-related neurodegeneration. We examined whether the microglial activation elicited by an NG-to-HG shift elevates the production of pro-inflammatory factors. To minimize the influence of different cell proliferation rates on assay parameters, cytosine arabinoside (ARA-C, 2 μM), which has no cell toxicity or oxygen free radical induction, was used (Supplementary Fig. 3). NG-cultured cells exposed to an NG-to-HG shift showed an obvious increase in TNF-α production at 48 h when compared with cells under constant NG conditions. The HG-to-NG shift in HG-cultured cells did not completely reduce TNF-α levels to those of NG-cultured cells in constant NG conditions within 48 h; however, a markedly lower TNF-α level was detected at 48 h in HG-cultured cells exposed to an HG-to-NG shift when compared with cells under constant HG conditions (Fig. 3a). The NG-to-HG shift caused an evident increase in NO production after 48 h when compared to constant NG conditions, while an HG-to-NG shift in HG-cultured cells effectively slowed NO production nearly to that of NG-cultured cells under constant NG conditions (Fig. 3b). The NG-to-HG shift also increased the production of oxygen free radicals when compared with constant NG conditions. A markedly higher formation of peroxides was observed at 24 h (Fig. 3c); likewise, the ROS production was clearly increased at 12 and 24 h (Fig. 3d). These results indicate a pro-inflammatory role of acute NG-to-HG fluctuation in the immune activation of microglia, as evidenced by increased production of TNF-α, NO, and oxygen free radicals.
Glucose fluctuations activate MAPKs and PI3K/Akt signaling pathways and alter NF-κB activity in microglia
Next, we examined the possible signaling cascades involved in our aforementioned results. Previous studies suggested that MAPKs participate in stress-associated cell activation and inflammation, whereas PI3K/Akt is involved in glucose metabolism and cell proliferation19,20,21. NF-κB plays a role in the pathogenesis of inflammatory diseases and is a crucial transcription factor for glial cell function22,23. So, the phosphorylation state of ERK, JNK, p38, and Akt as well as NF-κB activity were assessed in microglia after acute glucose fluctuations. An NG-to-HG shift in NG-cultured cells markedly increased the phosphorylation levels of ERK, JNK, p38, and Akt within 1 h when compared with constant NG conditions (Fig. 4a–e). Notably, the HG-to-NG shift in HG-cultured cells only activated p38 and Akt signalings (Fig. 4a,d,e). Additionally, levels of phosphorylated NF-κB p65 rapidly declined as early as 10 min following an NG-to-HG shift in NG-cultured cells, whereas an HG-to-NG shift in HG-cultured cells markedly elevated NF-κB p65 phosphorylation at 20 min (Fig. 5a,b). These NF-κB p65 phosphorylation events temporally parallel the changes in phosphorylated IKKα/β and IκBα levels (Fig. 5a,c,d). Our findings suggest that acute glucose fluctuations rapidly activate intracellular signaling cascades, particularly p38 and Akt, that trigger resting microglia to an active phenotype. NF-κB immediately reacts to glucose shifts and thus is a crucial factor of microglial activation even though its activity negatively correlates with the glucose concentration transition.
An NG-to-HG shift induces oxidative/inflammatory stress in microglia via MAPKs, PI3K/Akt, and NF-κB pathways
To determine the underlying signaling cascades that mediate stress-related activation responses, signaling pathway inhibitors, including BAY11-7082 (BAY; IκB phosphorylation inhibitor), PD98059 (PD; MEK/ERK inhibitor), SP600125 (SP; JNK inhibitor), SB203580 (SB; p38 inhibitor), and LY294002 (LY; PI3K inhibitor), were used in microglia. Compared to vehicle-treated cells exposed to an NG-to-HG shift, we found the following effects: 1) BAY, SP, SB, and LY effectively reduced HSP70 expression; 2) PD, SP, and SB substantially decreased HO-1 expression; 3) SP, SB, and LY markedly diminished iNOS expression; and 4) SP and SB notably weakened COX-2 expression (Fig. 6a and Supplementary Fig. 4). These results indicate that the NG-to-HG shift-induced expression of both stress and inflammatory proteins is mediated by a cooperation of distinct signaling cascades. HSP70 induction is mediated by NF-κB, whereas the PI3K/Akt pathway closely correlates with the neo-synthesis of HSP70 and iNOS. MAPKs, especially JNK, are major cascades mediating the upregulation of all inducible proteins. Regarding NG-to-HG shift-induced microglial proliferation, the JNK and PI3K/Akt are the main kinases involved, as evidenced by the SP- and LY-mediated inhibition of proliferation (Fig. 6b). All inhibitors clearly reduced NG-to-HG shift-induced TNF-α production (Fig. 6c). Consistent with the results above (Fig. 6a; iNOS blot), NO production closely correlated with the activation of JNK, p38, and PI3K/Akt pathways after an NG-to-HG shift (Fig. 6d). Moreover, the NG-to-HG shift-induced formation of peroxides was associated with the NF-κB, JNK, and PI3K/Akt pathways, as demonstrated by the effectiveness of BAY, SP, and LY (Fig. 6e). All used inhibitors, except BAY, clearly repressed the elevation of intracellular ROS induced by an NG-to-HG shift, thus indicating that NF-κB is not involved (Fig. 6f). These data suggest that among the examined signaling pathways, JNK is the most important kinase in the early response to an NG-to-HG shift because its activation is detectable in all episodes of oxidative/inflammatory stress.
LPS-induced microglial inflammation is strengthened by an NG-to-HG shift
We next assessed whether an NG-to-HG shift enhances LPS-induced inflammation in microglia. NG-cultured cells were treated with an NG-to-HG shift or simple medium renewal in the absence or presence of LPS for 24 h. Western blotting analyses showed that the expression of LPS-induced iNOS and COX-2 was substantially enhanced after an NG-to-HG shift when compared with LPS exposure in constant NG conditions (Fig. 7a). In comparison with LPS exposure under constant NG conditions, an NG-to-HG shift evidently increased LPS-induced NO production (≥ 1 μg/ml; Fig. 7b). Also, the NG-to-HG shift promoted LPS-induced inflammatory responses, including TNF-α, peroxides, and ROS productions (Fig. 7c–e). Therefore, these results clearly suggest that an acute fluctuation from NG to HG enlarges LPS-induced inflammation in microglia; in other words, microglia experiencing an NG-to-HG shift easily reach a fully-activated state and produce a greater response in the presence of inflammatory stimuli.
The HG-to-NG shift induces metabolic stress, causing microglial apoptosis and/or autophagy
The acute fluctuation from HG to NG is another concern for diabetes-related brain degeneration; hence, we examined microglial activity after an HG-to-NG shift. The deprivation of survival essentials, such as nutrients, can place cells in an adverse situation that triggers apoptosis or autophagy24. We found that an HG-to-NG shift in HG-cultured cells decreased Bcl-2 expression (an anti-apoptotic protein) and increased the cleaved form of caspase-3 (a key apoptotic caspase) after 24 h (Fig. 8a). The TUNEL assay, a common method to detect DNA strand breaks resulting from apoptosis, was used. A marked increase in the percentage of TUNEL-positive cells was observed after an HG-to-NG shift when compared with constant HG conditions (Fig. 8b,c). LC3-I is converted to LC3-II through lipidation during autophagy. We observed that the LC3B-II level was evidently increased on days 2 and 3 after HG-cultured cells were exposed to an HG-to-NG shift when compared with cells in constant HG conditions; also, cells maintained in constant NG conditions showed higher LC3B-II expression than cells exposed to an NG-to-HG shift (Fig. 8d). The extent of LC3B-II association with autophagic vesicles was immunocytochemically evaluated and visualized as red fluorescent puncta under a microscope. Quantitatively, more LC3B puncta were observed in HG-cultured cells exposed to an HG-to-NG shift when compared with cells maintained in constant HG conditions (Fig. 8e,f). Together, these data suggest that an acute fluctuation from HG to NG creates metabolic stress. If microglial maladaptation occurs under such a circumstance, apoptosis and/or autophagy ensues soon.
Discussion
DM leads to cognitive dysfunction and is a major contributor to dementia risk. Although studies have investigated the roles of many factors associated with diabetes-related brain complications, the etiological conditions leading to the pathogenesis of Alzheimer’s dementia have not been fully identified. As demonstrated by many clinical trials, these complications are ascribed to dysglycemia, which has two components: chronic hyperglycemia and acute glycemic fluctuations. The effects of these components on the brain are not well understood; nevertheless, their contribution to neurodegeneration may be due to altered microglial performance, which halts trophic support or exerts toxic effects. The varied microglial activities found in diabetic neuropathy presumably mediate and amplify brain complications12,13. Here, we characterized the impact of acute ambient glucose fluctuations on microglial activity and offered new insights into pathological mechanisms and therapeutic considerations for diabetic brain degeneration.
The causes of neurological dysfunction in diabetes can be broadly attributed to BBB leakage combined with cerebral metabolic alterations. The BBB protects brain parenchyma from variations in glucose, which cannot normally cross the BBB without the assistance of carriers or transporters; accordingly, neural cells responsive to glycaemic fluctuations suggest that the BBB integrity is compromised. Actually, compromised BBB integrity has been reported in some diabetic patients and experimental models. For example, BBB destruction occurred in hyperglycemic chorea patients25. Compared to non-diabetic patients, white matter lesions were frequently observed in diabetic patients26, implying diabetes-induced BBB disruption in clinical practice. In streptozotocin-induced diabetic rats, BBB permeability was enhanced by a decrease in tight junction proteins (i.e., occludin and ZO-1) and an increase in matrix metalloproteinase activity27. Additionally, complications commonly associated with diabetes, such as cerebral ischemia, hypertension, and hyperosmolality, disrupt the BBB integrity and thus allow biomolecules that are normally confined to the blood to enter the brain parenchyma28. BBB dysfunction is more pronounced in AD patients with peripheral vascular abnormalities, such as diabetes and cardiovascular diseases29. Following tight junction disruption, altered transport of biomolecules across the BBB, aberrant angiogenesis, vessel regression, brain hypoperfusion, and inflammatory responses that weaken synaptic plasticity and neuronal survival have been reported in AD patients7,30. Thus, cerebral metabolic variations, including glycemic fluctuations, may easily disturb neural cell activity under injured BBB conditions, leading to cognitive disability in the diabetic brain.
GLUTs are essential suppliers of glucose to neurons and glia within the brain. In the brain, GLUT2 serves as a central glucosensor to control food intake and is regulated by energy/glucose status31. Notably, we found that the expression level of GLUT2, but not GLUT1, was upregulated in response to ambient alterations from NG to HG. This elevated GLUT2 level might contribute to microglial activation and proliferation. Consistent with previous studies in pancreatic islet β-cells and hepatocytes, GLUT2 levels were passively increased by HG levels, in turn leading to augmented glucose influx and metabolism32,33. GLUT2 overexpression in GT1-7 neuroblastoma cells resulted in increased cellular ATP levels at 5 mM or higher glucose levels34. Although GLUT5, one of the primary GLUT isoforms in the brain, is specifically expressed in microglia, its regulation remains unclear. It was previously reported that microglial GLUT5 expression did not correlate with prolonged hyperglycemia35. In fact, GLUT5 has a much higher affinity for fructose than for glucose and is regarded as a fructose transporter. Fructose feeding in rats increased the expression of both GLUT5 mRNA and protein in the brain36. It is plausible that increased microglial GLUT5 expression promotes fructose utilization as an energy source if glucose utilization is impaired or glucose is not available. A study using human brain tissue samples (7 AD and 7 control brains) showed decreased GLUT1 and GLUT3 protein levels but a drastic increase in GLUT2 in the AD brain37. We determined that microglial GLUT2 positively correlated with glucose fluctuations; however, its role in the progression of diabetic neurodegeneration remains unclear and needs further exploration (please also see Supplementary information for extensive discussion on brain GLUTs).
Glucose is readily utilized by immunocompetent cells, such as microglia, to generate energy. Thus in this study, we speculate that the upregulation of GLUT2 by an NG-to-HG shift greatly increases glucose uptake/utilization, elevates the activity of the mitochondrial respiratory chain, promotes the production of more oxygen free radicals (e.g., ROS and NO), and leads to the formation of oxidative stress. Other sources of oxidative stress include glucose auto-oxidation, the polyol pathway with ensued depletion of antioxidant reserves, and the formation of AGEs38. Indeed, we found increased NO, peroxides and ROS production as well as the expression of the stress-inducible proteins HSP70 and HO-1 after microglia were exposed to an NG-to-HG shift. Stress conditions, such as global ischemia, sublytic NO exposure, or short-term HG exposure (30 mM), can induce HSP70 and/or HO-1 expression in injured neural cells and retinal endothelial cells15,16,39. We reasonably consider that an NG-to-HG fluctuation activates oxidative stress in microglia, which in turn induces HSP70 and HO-1 expression for resistance against stress insults.
In addition, the NG-to-HG shift also created inflammatory stress that activated microglia in the present study. Excessive ROS caused by dysglycemia can activate redox-sensitive pro-inflammatory transcription factors such as NF-κB, activator protein-1, and early growth response-1. The genes regulated by these transcription factors are inducible, as observed by an increased expression of various pro-inflammatory cytokines and chemokines (e.g., TNF-α, IL-6, and MCP-1) at the mRNA level in the monocytes and plasma23,40. Accordingly, diabetic inflammation occurs. An acute increase in circulating inflammatory cytokine levels as a result of hyperglycemia has been reported in diabetic patients18. Similarly, our results showed the activation of microglia after exposure to an NG-to-HG shift, which was accompanied by an inducible expression of iNOS and COX-2 and a marked elevation in TNF-α production. Additionally, NG-to-HG shift-stimulated pro-inflammatory conditions in microglia greatly enhanced LPS-induced inflammation. This illustrates that acute glucose elevation is a pro-inflammatory stimulus that enables microglia to reach a pre-activated or semi-activated state, while the enhancement of LPS-induced inflammation by an NG-to-HG shift might be ascribed to the upregulation of microglial GLUT2, followed by elevated glucose uptake and consumption. Likewise, increasing glucose (5.5 to 22 mM) worsened IL-1β-induced vascular inflammation even though no inflammatory effect was observed in the HG only condition41 (please also see Supplementary information for extensive discussion regarding the effect of glucose on LPS-induced inflammation).
With respect to constant NG- or HG-incubation conditions applied to BV-2 microglia, it is reasonable that a stable condition triggers no significant alterations in cell activity. Most likely, protein levels remain almost constant, presenting no detectable changes in the short term. As we expected, a consecutive maintenance for 1−3 days following a simple medium renewal (e.g., NG-to-NG or HG-to-HG) did not disturb the baseline expression levels (day 0) of all examined proteins in individual NG or HG circumstances (Supplementary Fig. 5).
Regarding the immediate signaling pathways that contribute to NG-to-HG shift-elicited oxidative/inflammatory stress, we found that MAPKs and PI3K/Akt mediated most stress episodes in microglia. Hyperglycemia-induced mitochondrial ROS can stimulate PKC, JNK, and p38 cascades, which amplify inflammation42. Activated p38 is important for cytokine synthesis and release, and JNK inhibition reduces the LPS-induced activity of inflammatory mediators in microglia19,43. In diabetes, AGEs activate the MEK/ERK, PI3K/Akt, and NF-κB pathways via RAGE, resulting in the upregulation of pro-inflammatory signals in an in vitro AD model using a microglial cell line8. As for inducible proteins, including HSP70, HO-1, iNOS, and COX-2, studies using animal and cell culture models under stress conditions have noted that signaling kinases and factors, such as MAPKs, PI3K/Akt, and NF-κB, mediate expression at the mRNA and protein levels19,44,45,46,47. Similar to past studies examining the effect of HG on cell proliferation48,49, we presented that an NG-to-HG shift stimulated microglial growth via JNK and PI3K pathways. Additionally, previous studies showed that the induction of iNOS or COX-2 is associated with active NF-κB22,23; however, in this study, we did not detect this association, nor did we find any inhibition of iNOS or COX-2 expression by increasing the dosage of BAY (Supplementary Fig. 6). By comparing the effectiveness of all signaling pathway inhibitors, we concluded that the JNK cascade is the most influential pathway contributing to oxidative/inflammatory stress and microglial activation following acute glucose fluctuations.
Cells respond to metabolic challenges, such as nutrient deprivation, by downregulating energy-consuming processes, such as proliferation and protein synthesis, and stimulating catabolic processes, such as autophagy. In cases of maladaptation, necrosis or apoptosis is a common occurrence. Autophagy upon glucose withdrawal was induced in cardiomyocyte-derived H9c2 cells, human hepatoma cells, and Chinese hamster ovary (CHO) cells50. The death of CHO cells triggered by glucose deprivation stimulated autophagic and apoptotic pathways24. Consistent with past findings, we observed increased caspase-3 cleavage and LC3B-II expression in microglia after exposure to an HG-to-NG shift. This clearly suggests that partial glucose deprivation creates metabolic stress that promotes both apoptotic and autophagic signal induction. Moreover, Bcl-2, an anti-apoptotic factor, inhibited autophagy in vivo and in vitro51. As expected, we found that reduced Bcl-2 expression was accompanied by the occurrence of apoptosis and autophagy after exposure of microglia to an HG-to-NG shift.
Following partial glucose deprivation, phosphorylated p38, Akt, and NF-κB were observed before the onset of apoptosis and autophagy. Apparently, active p38, Akt, and NF-κB cascades might be largely responsible for these self-degradative processes. As shown in previous studies, p38 is activated by a wide variety of environmental, oxidative, metabolic, and genotoxic stresses, which can induce both apoptosis and autophagy; even, p38 plays a key role in crosstalk between autophagy and apoptosis52. Additionally, elevated IKK/NF-κB activity has been reported to positively correlate with the activation of both apoptosis and autophagy. For example, NF-κB activation was induced by apoptotic stimuli, such as DNA damaging agents and ultraviolet radiation. In conditions of hyperglycemia or deprivation of amino acids and serum, autophagy was activated by the IKK/NF-κB pathway coupled to beclin-1 gene expression50. With respect to Akt, several lines of evidence suggest that glucose deprivation induces Akt activation20,53,54. From our results, Akt activation by an HG-to-NG shift might relate to compensatory feedback in response to an acute decline in ambient glucose; also, elevated Akt activity aims to reduce HG-to-NG shift-induced microglial degradation because PI3K/Akt is well known to promote cell survival and negatively regulate autophagy and apoptosis in different cell types55. We conjecture that activated p38 and NF-κB, but not Akt, play roles in mediating the cellular/molecular reactions needed for driving apoptosis and autophagy in microglia. Further studies are needed to elucidate this concept.
The energy depletion resulting from cells incubated in a glucose-free condition leads to an increase in the AMP/ATP ratio, which is sensed by AMP-activated protein kinase (AMPK) to induce autophagy56. However, we did not observe AMPK phosphorylation soon after microglial exposure to the HG-to-NG shift (Supplementary Fig. 7). Presumably, partial glucose deprivation (25 to 5.5 mM) in microglia is incapable of inducing a marked alteration of the AMP/ATP ratio that is sufficient to activate AMPK. Indeed, compared to the control (25 mM glucose), human tumor cells incubated under low glucose conditions (1 mM) showed no change in AMPK activity57, implying that AMPK is likely activated under glucose levels less than 1 mM or full glucose deprivation.
Glucose fluctuation surely accompanies the change of osmolality. Accordingly, high mannitol was included as a hyperosmolar control to test the impact of osmotic fluctuations per se on microglial activity. In this study, NG-to-HM shift-induced hyperosmolarity was unable to copy the effects we observed in BV-2 cultures that underwent an NG-to-HG shift, whereas the HG-to-HM shift could imitate the effects of the HG-to-NG shift on cell activity (Supplementary Fig. 8). Thus, the specific changes in microglial activity responding to NG-to-HG or HG-to-NG shifts might be ascribed not to osmotic fluctuations but to glucose-related metabolic alterations. In addition, to strengthen the novelty and verity of this study, several critical experiments related to glucose fluctuations were performed once more using primary rat microglial cultures, and the results were still reproducible and significant (Supplementary Fig. 9).
Conclusions
Overall, we determined that an NG-to-HG shift activates microglia, leading to cell growth and oxidative/inflammatory stress, whereas an HG-to-NG shift causes metabolic stress that activates microglial apoptosis and/or autophagy (Supplementary Fig. 10). The stress episodes are primarily mediated via the MAPK, PI3K/Akt, and NF-κB pathways. Increasing studies suggest that glycemic variability in the cerebral microvasculature closely correlates with the pathogenesis of diabetic cognitive decline and AD. Our data support this correlation and uncover how glycemic fluctuations disturb microglial activity if the BBB is disrupted. Altered microglial activity, such as inflammatory activation or self-degradation, may be an etiological factor for diabetic neurodegeneration. Future strategies to stabilize glycemic levels or microglial activity in the brain may be of great benefit for dementia therapy.
Methods
Chemicals, antibodies, and reagents
Tumor necrosis factor-α (TNF-α) ELISA kit was purchased from R&D Systems (Minneapolis, MN, USA). Terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) kit was purchased from BioVision Inc. (Mountain View, CA, USA). Phospho-ERK (pERK), pJNK, pp38, pAkt, pNF-κB p65, pIKKα/β, pIκBα, ERK, JNK, p38, Akt, NF-κB p65, IKKα/β, IκBα, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), heat shock protein 70 (HSP70), and cleaved caspase-3 antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Heme oxygenase-1 (HO-1) and light chain 3B (LC3B) antibodies were purchased from Enzo Life Sciences (Farmingdale, NY, USA). Bcl-2, GAPDH, glucose transporter type 1, 2 and 5 (GLUTs 1, 2 and 5) antibodies, BAY11-7082 agent, and small interfering RNA (siRNA) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Alexa Fluor 568-conjugated IgG and HRP-conjugated secondary antibody were obtained separately from Life Technologies (Carlsbad, CA, USA) and Jackson ImmunoResearch Laboratories (West Grove, PA, USA). 2′7′-Dichlorodihydrofluorescein diacetate (H2DCFDA) and dihydrorhodamine-1,2,3 (DHR-123) were purchased from Molecular Probes (Invitrogen, Carlsbad, CA, USA). PD98059, SP600125, SB203580, and LY294002 agents were obtained from Selleckchem (Houston, TX, USA). Culture reagents were obtained from Gibco-BRL/Invitrogen (Carlsbad, CA, USA). All chemicals were from Sigma-Aldrich (Saint Louis, MO, USA) unless stated otherwise.
Cell cultures and glucose concentration shift
The mouse microglial BV-2 cell line was cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 1 mM sodium pyruvate and 1% penicillin/streptomycin at 37 °C in a humidified atmosphere of 95% air/5% CO2. Confluent cultures were passaged twice each week by trypsinization. Before proceeding with this study, BV-2 microglia were separated into two lines: normal glucose (NG; 1 g/L, 5.5 mM)-cultured cells and high glucose (HG; 4.5 g/L, 25 mM)-cultured cells. In the experiments involving acute glucose fluctuations, cell media was replaced by fresh media with a shift of NG-to-HG or HG-to-NG. An NG-to-HG shift indicates that the media for NG-cultured cells was replaced by HG media, whereas the HG-to-NG shift means that the media for HG-cultured cells was changed to NG media. A constant NG or HG condition signifies that the media was renewed without concentration alteration. Cells were also incubated in a high mannitol concentration (HM, 5.5 mM glucose plus 19.5 mM mannitol) to provide a purely hyperosmolar control. In addition, primary rat microglia cells were also prepared. Please see Supplementary information for details.
RNA interference (RNAi) using siRNA
Prior to transfection, cultures were maintained in antibiotic-free medium for 18−24 h. Cells in 6-well culture plates were transfected with 100 pmol of siRNA duplex using Lipofectamine 2000 and Opti-MEM (Invitrogen, Carlsbad, CA), as per the manufacturer’s protocol. After incubating the transfected cells for 6 h, culture media was replaced by fresh media containing 10% FBS. Western blotting was used for determining the siRNA knockdown effect on target protein. All siRNA oligos were designed and synthesized by Santa Cruz Biotechnology. Mouse GLUT2 siRNA (sc-35496) is a pool of 3 target-specific 19–25 nt siRNAs. The specific sequences are as follows: i) GLUT2 siRNA-1 sense, 5′-CUGCUCACAUAGUCACUAUTT-3′ and antisense, 5′-AUAGUGACUAUGUGAGCAGTT-3′; ii) GLUT2 siRNA-2 sense, 5′-CUACAACUGCUAUCUAGAUTT-3′ and antisense, 5′-AUCUAGAUAGCAGUUGUAGTT-3′; iii) GLUT2 siRNA-3 sense, 5′-CUUCAGUCUUUGUGUUGUATT-3′ and antisense, 5′-UACAACACAAAGACUGAAGTT-3′. Control siRNA (sc-37007) is a non-targeting 20–25 nt siRNA designed as a negative control and leads to no degradation of any known cellular mRNA. The manufacturer does not offer the sequence of scrambled control siRNA.
Measurements of cell proliferation and viability
Cell proliferation was determined using a tetrazolium-based colorimetric assay (MTT), which measures only in vitro living cells and reveals the results related to the number of viable cultured cells. MTT (0.5 mg/mL) dissolved in PBS was added to the cells for 2 h of incubation at 37 °C. After removing MTT-containing medium, the produced purple formazan was dissolved in dimethyl sulfoxide and then measured at 570 nm against a 620-nm reference wavelength (ΔOD, OD: optical density) using a Multiskan microplate photometer (Thermo Fisher Scientific, Waltham, MA, USA). Additionally, a trypan blue exclusion assay was applied to calculate the number of viable cells, which serves as a direct method to measure cell proliferation. Initially, cells were seeded into 24-well plates at a density of 1 × 104 cells per well and exposed to an acute glucose shift the next day. At the indicated time points, cells were removed from the culture plates by trypsin-EDTA and stained with trypan blue for the cell count in Cellometer Auto T4 Cell Counter (Nexcelom Bioscience, Lawrence, MA, USA). For the cell viability assay, cell survival was determined by the VisionBlue™ Quick Cell Viability Fluorometric Assay Kit (BioVision, Mountain View, CA, USA) according to the manufacturer’s instructions. For details, please see Supplementary information.
Measurement of nitrite accumulation
Since NO itself is unstable, NO production was determined by measuring nitrite, a stable oxidation product of NO. The extent of nitrite released into the medium was measured by a spectrophotometric assay based on the Griess reaction, as described by our previous works15,17.
Determination of intracellular oxygen free radicals
Reactive oxygen species (ROS) were determined by estimating the fluorescence intensity from cultures after loading with cell-permeable fluorogenic probes H2DCFDA, which detects ROS and assesses the degree of overall oxidative stress, and DHR-123, which detects peroxide and peroxynitrite. After finishing the indicated treatments, cultures were washed once and replaced by fresh PBS. Then cells were incubated with H2DCFDA (10 μM) or DHR-123 (20 μM) for 30 min at 37 °C. The fluorescence of H2DCFDA undergoing ROS oxidation was measured at λex = 485 nm and λem = 528 nm while the intensity of fluorescent DHR-123 oxidation product (rhodamine 123) was measured at λex = 488 nm and λem = 515 nm by using a fluorometric microplate reader (FLx800 Fluorescence Reader, BioTek Instruments, Inc.). All fluorescence intensity readings (relative fluorescence unit, RFU) were normalized to the background value before comparing the sample to the untreated control.
Immunofluorescence staining of LC3B
Cells grown on glass coverslips were fixed with 4% paraformaldehyde, permeabilized, blocked with 3% BSA/2% goat serum, and incubated with the LC3B antibody at 4 °C overnight. After washes, cells were incubated with the corresponding secondary antibody conjugated with Alexa Fluor 568 in dark for 2 h and analyzed using a laser confocal microscope (MRC-1000; Bio-Rad, Hercules, CA; LSM510 META, Carl Zeiss, Oberkochen, Germany). 4′, 6-diamidino-2-phenylindole (DAPI) was used to label cell nucleus. To assess autophagy, the cells with punctate LC3B fluorescence were specially noted and total number of LC3B puncta per DAPI-labelled cell was counted. At least 200 cells were examined in each treatment group per experiment. A comparison of LC3B puncta formation per cell between the indicated groups was performed.
Enzyme-linked immunosorbent assay (ELISA) for TNF-α
A commercial ELISA kit was applied to estimate the levels of mouse TNF-α released from cultured cells according to the manufacturer’s instructions.
TUNEL assay
According to the manufacturer’s instructions, a TUNEL assay was applied to detect apoptosis. The TUNEL-positive cells were visualized under an inverted fluorescence microscope (Nikon ECLIPSE Ts2 microscope, Nikon, Inc.) equipped with a standard FITC filter and a digital camera (Diagnostic Instruments, Sterling Heights, MI, USA). For quantification, matching bright-field and fluorescent TUNEL-FITC photos were taken for each field. At least 25 fields were examined in each treatment group per experiment. The cell percentage showing fluorescent TUNEL-positive nuclei in a single field is determined by assuming a 100% of total cell number in the matching bright-field photo.
Western blots
Cells were harvested in ice-cold RIPA buffer (50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) containing protease and phosphatase inhibitors (Gold Biotechnology Inc., St. Louis, MO, USA). Lysis occurred on ice for 20 min and then total lysates were cleared by centrifugation at 14,000 × g for 10 min (4 °C). A Bio-Rad protein assay was used for protein quantification (Bio-Rad, Hercules, CA, USA). Cell lysate (40 μg) was resolved by SDS–polyacrylamide gel electrophoresis and electroblotted onto polyvinylidene fluoride membranes (Millipore, Bedford, MA, USA). After blocking (5% non-fat dry skim milk), the membranes were immunoblotted for desired proteins. The immunoblots developed on X-ray film were visualized by an enhanced chemiluminescence system (Amersham Biosciences, Piscataway, NJ, USA). The intensities of the protein bands were quantified using Image J software (NIH, Bethesda, Maryland, USA).
Statistical analysis
SigmaStat version 4.0 software from Jandel Scientific (San Diego, CA, USA) was applied. For experiments involving multiple treatment groups, statistical significant difference was analyzed using one-way ANOVA, followed by Dunnett’s test or Bonferroni’s t-test. For analysis between two groups, an independent sample t-test (2-tailed) was used to evaluate differences. All data are presented as mean ± standard error of the mean (SEM). A value was considered significant if the probability value was less than 0.05 (p < 0.05).
Data Availability
All data generated or analyzed during this study are included in this published article and its Supplementary information files.
References
Ninomiya, T. Diabetes mellitus and dementia. Curr Diab Rep 14, 487, https://doi.org/10.1007/s11892-014-0487-z (2014).
Umegaki, H. Neurodegeneration in diabetes mellitus. Adv Exp Med Biol 724, 258–265, https://doi.org/10.1007/978-1-4614-0653-2_19 (2012).
Kawamura, T., Umemura, T. & Hotta, N. Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig 3, 413–423, https://doi.org/10.1111/j.2040-1124.2012.00234.x (2012).
Pugazhenthi, S., Qin, L. & Reddy, P. H. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta 1863, 1037–1045, https://doi.org/10.1016/j.bbadis.2016.04.017 (2017).
Sridhar, G. R., Lakshmi, G. & Nagamani, G. Emerging links between type 2 diabetes and Alzheimer’s disease. World J Diabetes 6, 744–751, https://doi.org/10.4239/wjd.v6.i5.744 (2015).
Rizzo, M. R. et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care 33, 2169–2174, https://doi.org/10.2337/dc10-0389 (2010).
Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178–201, https://doi.org/10.1016/j.neuron.2008.01.003 (2008).
Dukic-Stefanovic, S., Gasic-Milenkovic, J., Deuther-Conrad, W. & Munch, G. Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J Neurochem 87, 44–55 (2003).
Muriach, M., Flores-Bellver, M., Romero, F. J. & Barcia, J. M. Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev 2014, 102158, https://doi.org/10.1155/2014/102158 (2014).
Cui, X., Abduljalil, A., Manor, B. D., Peng, C. K. & Novak, V. Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes. PLoS One 9, e86284, https://doi.org/10.1371/journal.pone.0086284 (2014).
Elahi, M. et al. Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice. J Alzheimers Dis 51, 1209–1224, https://doi.org/10.3233/JAD-150820 (2016).
Hwang, I. K. et al. Activation of microglia and induction of pro-inflammatory cytokines in the hippocampus of type 2 diabetic rats. Neurol Res 36, 824–832, https://doi.org/10.1179/1743132814Y.0000000330 (2014).
Nagayach, A., Patro, N. & Patro, I. Astrocytic and microglial response in experimentally induced diabetic rat brain. Metab Brain Dis 29, 747–761, https://doi.org/10.1007/s11011-014-9562-z (2014).
Bogush, M., Heldt, N. A. & Persidsky, Y. Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition. J Neuroimmune Pharmacol 12, 593–601, https://doi.org/10.1007/s11481-017-9752-7 (2017).
Wang, J. Y., Lee, C. T. & Wang, J. Y. Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia. Neuroscience 281C, 164–177, https://doi.org/10.1016/j.neuroscience.2014.09.048 (2014).
Gaspary, H., Graham, S. H., Sagar, S. M. & Sharp, F. R. HSP70 heat shock protein induction following global ischemia in the rat. Brain Res Mol Brain Res 34, 327–332 (1995).
Yu, L. E., Lai, C. L., Lee, C. T. & Wang, J. Y. Highly electronegative low-density lipoprotein L5 evokes microglial activation and creates a neuroinflammatory stress via Toll-like receptor 4 signaling. J Neurochem 142, 231–245, https://doi.org/10.1111/jnc.14053 (2017).
Esposito, K. et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106, 2067–2072 (2002).
Waetzig, V. et al. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 50, 235–246, https://doi.org/10.1002/glia.20173 (2005).
Schultze, S. M., Hemmings, B. A., Niessen, M. & Tschopp, O. PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med 14, e1, https://doi.org/10.1017/S1462399411002109 (2012).
Gehart, H., Kumpf, S., Ittner, A. & Ricci, R. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep 11, 834–840, https://doi.org/10.1038/embor.2010.160 (2010).
O’Neill, L. A. & Kaltschmidt, C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20, 252–258 (1997).
Park, M. H. & Hong, J. T. Roles of NF-kappaB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches. Cells 5, https://doi.org/10.3390/cells5020015 (2016).
Hwang, S. O. & Lee, G. M. Nutrient deprivation induces autophagy as well as apoptosis in Chinese hamster ovary cell culture. Biotechnol Bioeng 99, 678–685, https://doi.org/10.1002/bit.21589 (2008).
Iwata, A., Koike, F., Arasaki, K. & Tamaki, M. Blood brain barrier destruction in hyperglycemic chorea in a patient with poorly controlled diabetes. J Neurol Sci 163, 90–93 (1999).
Manschot, S. M. et al. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50, 2388–2397, https://doi.org/10.1007/s00125-007-0792-z (2007).
Hawkins, B. T., Lundeen, T. F., Norwood, K. M., Brooks, H. L. & Egleton, R. D. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50, 202–211, https://doi.org/10.1007/s00125-006-0485-z (2007).
Mooradian, A. D. Central nervous system complications of diabetes mellitus–a perspective from the blood-brain barrier. Brain Res Brain Res Rev 23, 210–218 (1997).
Goldwaser, E. L., Acharya, N. K., Sarkar, A., Godsey, G. & Nagele, R. G. Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer’s Disease. J Alzheimers Dis 54, 445–456, https://doi.org/10.3233/JAD-160284 (2016).
Daulatzai, M. A. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s disease. J Neurosci Res 95, 943–972, https://doi.org/10.1002/jnr.23777 (2017).
Thorens, B. G. L. U. T. 2 glucose sensing and glucose homeostasis. Diabetologia 58, 221–232, https://doi.org/10.1007/s00125-014-3451-1 (2015).
Ferrer, J., Gomis, R., Fernandez Alvarez, J., Casamitjana, R. & Vilardell, E. Signals derived from glucose metabolism are required for glucose regulation of pancreatic islet GLUT2 mRNA and protein. Diabetes 42, 1273–1280 (1993).
Rencurel, F. et al. Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver. Biochem J 314(Pt 3), 903–909 (1996).
Li, B., Lee, K. & Martin, R. J. Overexpression of glucose transporter 2 in GT1-7 cells inhibits AMP-activated protein kinase and agouti-related peptide expression. Brain Res 1118, 1–5, https://doi.org/10.1016/j.brainres.2006.08.032 (2006).
Polito, A. et al. Hyperglycaemia and apoptosis of microglial cells in human septic shock. Crit Care 15, R131, https://doi.org/10.1186/cc10244 (2011).
Shu, H. J., Isenberg, K., Cormier, R. J., Benz, A. & Zorumski, C. F. Expression of fructose sensitive glucose transporter in the brains of fructose-fed rats. Neuroscience 140, 889–895, https://doi.org/10.1016/j.neuroscience.2006.02.071 (2006).
Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I. & Gong, C. X. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582, 359–364, https://doi.org/10.1016/j.febslet.2007.12.035 (2008).
Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ Res 107, 1058–1070, https://doi.org/10.1161/CIRCRESAHA.110.223545 (2010).
Castilho, A. et al. Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity. PLoS One 7, e42428, https://doi.org/10.1371/journal.pone.0042428 (2012).
Aljada, A. et al. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr 80, 51–57 (2004).
Lafuente, N. et al. The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning. J Hypertens 26, 478–485, https://doi.org/10.1097/HJH.0b013e3282f331fb (2008).
Sivitz, W. I. & Yorek, M. A. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 12, 537–577, https://doi.org/10.1089/ars.2009.2531 (2010).
Ji, R. R. & Suter, M. R. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 3, 33, https://doi.org/10.1186/1744-8069-3-33 (2007).
Bae, J. H. et al. Manganese induces inducible nitric oxide synthase (iNOS) expression via activation of both MAP kinase and PI3K/Akt pathways in BV2 microglial cells. Neurosci Lett 398, 151–154, https://doi.org/10.1016/j.neulet.2005.12.067 (2006).
Banerjee Mustafi, S., Chakraborty, P. K., Dey, R. S. & Raha, S. Heat stress upregulates chaperone heat shock protein 70 and antioxidant manganese superoxide dismutase through reactive oxygen species (ROS), p38MAPK, and Akt. Cell Stress Chaperones 14, 579–589, https://doi.org/10.1007/s12192-009-0109-x (2009).
Chen, K. & Maines, M. D. Nitric oxide induces heme oxygenase-1 via mitogen-activated protein kinases ERK and p38. Cell Mol Biol (Noisy-le-grand) 46, 609–617 (2000).
Nieminen, R., Lahti, A., Jalonen, U., Kankaanranta, H. & Moilanen, E. JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages. Int Immunopharmacol 6, 987–996, https://doi.org/10.1016/j.intimp.2006.01.009 (2006).
Kim, Y. H., Heo, J. S. & Han, H. J. High glucose increase cell cycle regulatory proteins level of mouse embryonic stem cells via PI3-K/Akt and MAPKs signal pathways. J Cell Physiol 209, 94–102, https://doi.org/10.1002/jcp.20706 (2006).
Zhang, L. et al. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-kappaB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. Int J Biochem Cell Biol 44, 629–638, https://doi.org/10.1016/j.biocel.2012.01.001 (2012).
Moruno, F., Perez-Jimenez, E. & Knecht, E. Regulation of autophagy by glucose in Mammalian cells. Cells 1, 372–395, https://doi.org/10.3390/cells1030372 (2012).
Pattingre, S. et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927–939, https://doi.org/10.1016/j.cell.2005.07.002 (2005).
Sui, X. et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett 344, 174–179, https://doi.org/10.1016/j.canlet.2013.11.019 (2014).
Gao, M. et al. Site-specific activation of AKT protects cells from death induced by glucose deprivation. Oncogene 33, 745–755, https://doi.org/10.1038/onc.2013.2 (2014).
von der Crone, S. et al. Glucose deprivation induces Akt-dependent synthesis and incorporation of GLUT1, but not of GLUT4, into the plasma membrane of 3T3-L1 adipocytes. Eur J Cell Biol 79, 943–949, https://doi.org/10.1078/0171-9335-00118 (2000).
Maiese, K., Chong, Z. Z., Shang, Y. C. & Wang, S. Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets 16, 1203–1214, https://doi.org/10.1517/14728222.2012.719499 (2012).
Meley, D. et al. AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 281, 34870–34879, https://doi.org/10.1074/jbc.M605488200 (2006).
Yin, L., Kharbanda, S. & Kufe, D. MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation. Int J Oncol 34, 1691–1699 (2009).
Acknowledgements
This work was supported in part by the grants (MOST 104-2314-B-037-069 and MOST 104-2314-B-037-025) from the Ministry of Science and Technology, Taiwan; and the grants (KMU-TP103D01 and KMU-TP103D02) from Kaohsiung Medical University, Taiwan.
Author information
Authors and Affiliations
Contributions
C.F.H. and C.K.L. contribute the same efforts to this study. Both designed/performed the experiments, analyzed/interpreted the data, and drafted the manuscript. C.T.L. and L.E.Y. carried out cell culture and assisted in executing biochemical assays. J.Y.W. conceived of the study, participated in the design and coordination, and revised/submitted the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hsieh, CF., Liu, CK., Lee, CT. et al. Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation. Sci Rep 9, 840 (2019). https://doi.org/10.1038/s41598-018-37215-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-37215-0
- Springer Nature Limited
This article is cited by
-
High sugar consumption for seven days in adult mice increased blood glucose variability, induced an anxiolytic effect and triggered oxidative stress in cerebral cortex
Metabolic Brain Disease (2024)
-
Glial cell alterations in diabetes-induced neurodegeneration
Cellular and Molecular Life Sciences (2024)
-
Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies
Journal of Neuroinflammation (2023)
-
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
Translational Neurodegeneration (2023)
-
Sesamin protects against neurotoxicity via inhibition of microglial activation under high glucose circumstances through modulating p38 and JNK signaling pathways
Scientific Reports (2022)